Clinical studies of tosufloxacin on chronic bacterial prostatitis
In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method. Nineteen patients who were evaluated by the UTI criteria we...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 7 vom: 01. Juli, Seite 673-8 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1993
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Clinical Trial English Abstract Journal Article Multicenter Study Anti-Infective Agents Fluoroquinolones Naphthyridines Tablets tosufloxacin GHJ553KQPS |